Hennepin County Medical Center

Robins Kaplan Announces Settlements Totaling $8.875 Million With City of Minneapolis in Two 2017 Police Misconduct Cases Involving Derek Chauvin, Multiple Other Officers

Retrieved on: 
Thursday, April 13, 2023

On behalf of its clients John Pope and Zoya Code, Robins Kaplan LLP announced today two settlements, totaling $8,875,000, with the City of Minneapolis.

Key Points: 
  • On behalf of its clients John Pope and Zoya Code, Robins Kaplan LLP announced today two settlements, totaling $8,875,000, with the City of Minneapolis.
  • Chauvin was never disciplined for these incidents by the MPD, which had possession of the video evidence of his misconduct.
  • In 2017, John Pope was 14 years old when MPD was called to his house for a domestic disturbance.
  • Robins Kaplan partner Bob Bennett, who represented Pope and Code, issued the following statement:
    “Beware the ease of blaming Chauvin alone.

Nancy J. Mendelsohn, MD, FACMG, Accomplished Healthcare Leader and Medical Geneticist, is Elected President of the ACMG Foundation for Genetic and Genomic Medicine

Retrieved on: 
Thursday, March 16, 2023

BETHESDA, Md., March 16, 2023 /PRNewswire/ -- Nancy J. Mendelsohn, MD, FACMG has been elected as president of the ACMG Foundation for Genetic and Genomic Medicine.

Key Points: 
  • BETHESDA, Md., March 16, 2023 /PRNewswire/ -- Nancy J. Mendelsohn, MD, FACMG has been elected as president of the ACMG Foundation for Genetic and Genomic Medicine.
  • The ACMG Foundation is a national nonprofit foundation dedicated to improving health and patient care through the support of research, education and the safe, effective practice of genetic and genomic medicine.
  • "I am delighted that Dr. Nancy Mendelsohn will succeed me as president of the ACMG Foundation.
  • Dr. Mendelsohn is an accomplished medical geneticist with broad experience both in clinical practice and the administration and management of medical genetics services.

AAOS Recognizes Alex Jahangir, MD, FAAOS, with Highest Leadership Award, Honoring a Career Devoted to Public Health in the City of Nashville

Retrieved on: 
Thursday, March 9, 2023

The Tipton Leadership Award recognizes AAOS members who have demonstrated outstanding leadership qualities that have benefitted the orthopaedic community, patients and/or the American public.

Key Points: 
  • The Tipton Leadership Award recognizes AAOS members who have demonstrated outstanding leadership qualities that have benefitted the orthopaedic community, patients and/or the American public.
  • "The greatest honor of my professional career is receiving the William W. Tipton Jr.
  • Ours is a specialty that disproportionately produces many leaders in our practices, our communities and our nation.
  • While serving as chair of the Metropolitan Board of Health Nashville, Dr. Jahangir was named chair of the Metropolitan Nashville COVID-19 Taskforce by Mayor John Cooper.

Cardiac Dimensions Appoints Angie Swenson as Vice President, Clinical Operations

Retrieved on: 
Thursday, January 26, 2023

Cardiac Dimensions ®, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, today announced the appointment of Angie Swenson as Vice President of Clinical Operations.

Key Points: 
  • Cardiac Dimensions ®, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, today announced the appointment of Angie Swenson as Vice President of Clinical Operations.
  • Ms. Swenson has spent most of the last 20 years leading clinical trials in the U.S., Europe, Japan and Canada and collaborating on reimbursement strategies for therapies targeting cardiovascular disease developed by leading medtech innovators.
  • Most recently, she served as Vice President, Clinical and Regulatory for HLT, Inc., developer of transcatheter aortic heart valve replacement (TAVR) technology, where for five years she led their early feasibility studies.
  • Earlier in her career, she worked for Beckman Coulter as a Clinical Studies Scientist validating projects for FDA submissions.

Vireo Health of Minnesota Appoints Amber Shimpa as Chief Executive Officer

Retrieved on: 
Monday, February 13, 2023

MINNEAPOLIS, Feb. 13, 2023 /PRNewswire/ -- Vireo Health of Minnesota, LLC ("Vireo" or the "Company"), a physician-founded medical cannabis company based in Minneapolis, today announced that Amber Shimpa has been appointed as Chief Executive Officer, effective immediately. Ms. Shimpa's appointment to the role follows eight years of cross-organizational leadership at the Company, including serving as the Company's first Chief Financial Officer when it began operating under the name Minnesota Medical Solutions.

Key Points: 
  • MINNEAPOLIS, Feb. 13, 2023 /PRNewswire/ -- Vireo Health of Minnesota, LLC ("Vireo" or the "Company"), a physician-founded medical cannabis company based in Minneapolis, today announced that Amber Shimpa has been appointed as Chief Executive Officer, effective immediately.
  • Ms. Shimpa's appointment to the role follows eight years of cross-organizational leadership at the Company, including serving as the Company's first Chief Financial Officer when it began operating under the name Minnesota Medical Solutions.
  • Amber Shimpa commented, "I'm proud to join Kyle in this new role and lead Vireo into the future.
  • Vireo Health of Minnesota began serving medical cannabis products to Minnesota patients in 2015.

Provation Celebrates One Million Clinical Procedure Notes Documented in Cloud-Based Provation® Apex Software

Retrieved on: 
Wednesday, January 11, 2023

Minneapolis, Minn., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Provation, a leading provider of healthcare productivity and workflow automation software solutions, today announced over one million clinical procedure notes documented in cloud-based Provation® Apex .

Key Points: 
  • Minneapolis, Minn., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Provation, a leading provider of healthcare productivity and workflow automation software solutions, today announced over one million clinical procedure notes documented in cloud-based Provation® Apex .
  • Provation Apex was also developed to help healthcare organizations combat rising cybersecurity concerns, resource constraints, and tech debt.
  • “Our goal with Provation Apex is to take everything we’ve learned over the years about healthcare productivity and workflow automation and use it to develop the ultimate SaaS procedure documentation platform.
  • Provation acquired on-premises procedure documentation solutions MD-Reports and endoPRO in 2019 and 2021 respectively, and facilities using these solutions are migrating to Provation Apex in waves, too.

Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary

Retrieved on: 
Thursday, March 17, 2022

SEOUL, South Korea, March 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today announced the appointment of Glen Hansen, Ph.D., D(ABMM), FCCM, as the Head of Scientific and Medical Affairs of its United States subsidiary, Seegene Technologies .

Key Points: 
  • SEOUL, South Korea, March 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today announced the appointment of Glen Hansen, Ph.D., D(ABMM), FCCM, as the Head of Scientific and Medical Affairs of its United States subsidiary, Seegene Technologies .
  • Dr. Hansen has decades of real-world and clinical experience as a microbiologist specializing in molecular diagnostics and medical microbiology.
  • Prior to joining Seegene, he was the Medical Director of the Microbiology and Molecular Diagnostics Laboratory at Hennepin County Medical Center in Minneapolis and the University of Minnesota School of Medicine.
  • Dr. Hansen graduated with honors from the University of Saskatchewan where he earned dual bachelor's degrees in Microbiology and Immunology.

Kimberly Parrish Joins Currance as Chief Operating Officer (COO)

Retrieved on: 
Tuesday, February 22, 2022

IRVINE, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Currance, a leading healthcare revenue cycle industry innovator, announces the appointment of Kimberly Parrish to the position of Chief Operating Officer (COO).

Key Points: 
  • IRVINE, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Currance, a leading healthcare revenue cycle industry innovator, announces the appointment of Kimberly Parrish to the position of Chief Operating Officer (COO).
  • Kimberly is a nationally recognized leader in revenue cycle consulting with over 30 years in healthcare management.
  • "In our continuing effort to exceed client expectations, we are excited to welcome Kimberly Parrish to Currance as our Chief Operating Officer.
  • Kim's revenue cycle insight will support our senior leadership's focus on solution innovation and exceptional customer support," said Michael Halberda, CEO of Currance.

Hyperfine Appoints Chip Truwit, M.D. as Senior Medical Director

Retrieved on: 
Tuesday, February 8, 2022

GUILFORD, Conn., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Hyperfine Inc. (Nasdaq:HYPR), creator of Swoop, the first FDA-cleared portable magnetic resonance imaging (MRI) system, today announced the appointment of Dr. Chip Truwit as senior medical director.

Key Points: 
  • GUILFORD, Conn., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Hyperfine Inc. (Nasdaq:HYPR), creator of Swoop, the first FDA-cleared portable magnetic resonance imaging (MRI) system, today announced the appointment of Dr. Chip Truwit as senior medical director.
  • We feel privileged to welcome Dr. Truwit to the Hyperfine team, Khan Siddiqui, M.D., Hyperfine's chief medical officer and chief strategy officer, said.
  • Before joining Hyperfine, Truwit served as chief medical officer of diagnostic imaging and medical officer of precision diagnosis at Philips Healthcare, where he provided medical leadership and radiology expertise.
  • Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the worlds first FDA-cleared portable MRI system.

Nancy J. Mendelsohn, MD, FACMG Is Elected to the ACMG Foundation for Genetic and Genomic Medicine Board of Directors

Retrieved on: 
Tuesday, January 11, 2022

BETHESDA, Md., Jan. 11, 2022 /PRNewswire/ -- Nancy J. Mendelsohn, MD, FACMG has been elected to the board of directors of the ACMG Foundation for Genetic and Genomic Medicine .

Key Points: 
  • BETHESDA, Md., Jan. 11, 2022 /PRNewswire/ -- Nancy J. Mendelsohn, MD, FACMG has been elected to the board of directors of the ACMG Foundation for Genetic and Genomic Medicine .
  • The ACMG Foundation is a national nonprofit foundation dedicated to facilitating the integration of genetics and genomics into medical practice.
  • The board members are active participants, serving as advocates for the ACMG Foundation and advancing its policies and programs.
  • "Dr. Mendelsohn brings to the ACMG Foundation a unique skill set combining expertise in medical genetics, practice management, and health system leadership.